A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

United Therapeutics

ClinicalTrials.gov Identifier:

NCT00058929

First received: April 14, 2003

Last updated: March 5, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2005
Primary Completion Date:	August 2005 (Final data collection date for primary outcome measure)